Health Enterprise Partners (HEP) is a New York-based lower-middle-market private equity firm focused exclusively on healthcare services and healthcare information technology companies. The firm targets revenue-positive companies with consistent cash flow, making both control and minority growth equity investments.
67% of their portfolio is in Healthcare. They made 1 investment in the last 12 months. Average disclosed round size is $18.4M (across 17 rounds with reported amounts).
Portfolio
14
Fund Size
—
Top Stage
Series B
Last 12 Mo
1
Team
Rick Stowe
Co-Founder & Partner Emeritus
Bill Lucia
HEP Executive Partner
Holly Lorenz
HEP Executive Partner
Jeff Butler
HEP Executive Partner
Mark McAdoo
HEP Executive Partner
Natasha Deckmann, MD
HEP Executive Partner
Phil Okala
HEP Executive Partner
Roland Lyon
Operating Partner
Samir Malik
HEP Executive Partner
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 PatientIQ | Series C | $30M | Sep 2026 |
 nOCD | Series C | $34M | Jan 2023 |
 Alivia Analytics | Unknown | — | Oct 2022 |
| PatientIQ | Series B | $20M | May 2022 |
| nOCD | Series B | $33M | Sep 2021 |
 Kno2 | Series A | $15M | Jul 2021 |
 Aware Recovery Care | Unknown | — | Jan 2021 |
| nOCD | Series A | — | Oct 2020 |
 Twistle | Series A | $16M | Oct 2019 |
| BBardydx | Series B | — | Apr 2019 |
 Catapult Health | Series B | $10M | Nov 2016 |
| SShyft Analytics | Series B | $12.5M | Aug 2016 |
| SShyft Analytics | Series B | $12.5M | Jan 2016 |
| EEvariant | Series C | $42.3M | Dec 2015 |
| CContinuumRx | Unknown | $13.5M | Jan 2015 |
| EEvariant | Series B | $18M | Jan 2014 |
| CContinuumRx | Unknown | $7M | Jan 2012 |
 Wildflower Health | Series C | $26M | — |
| EEvariant | Series A | $5.3M | — |
| AAxiaMed | Unknown | $12.4M | — |
| AApplied Pathways | Series A | $6M | — |
Top Co-Investors
Last updated: 20 October 2026